PresidentIsabelle De Bie, MD, PhD, FRCPC, FCCMG

debie isabelle 200Dr. Isabelle De Bie is a Clinical and Molecular Geneticist. She initially trained in Biochemistry, Immunology, then Molecular Biology, before undertaking her Royal College training in Medical Genetics, followed by a CCMG fellowship in Molecular Genetics.
She currently heads the prenatal diagnosis program and acts as clinical director of the Core Molecular Diagnostics Laboratory at the McGill University Health Centre. Her areas of interest span both pre and postnatal dysmorphology, in particular skeletal dysplasias.
She contributed to several guidelines and positions statements as a member of the CCMG Clinical Practice committee and as CCMG representative to the SOGC Genetics committee.
She is a supporter of the international “Choosing Wisely” campaign, which advocates for clinically relevant medical care.

President Elect: Elizabeth (Liz) McCready, PhD, MSc, FCCMG

mccready 200Dr. McCready is an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University and Head of Molecular Cytogenetics within the Hamilton Regional Laboratory Medicine Program (HRLMP) Genetics Laboratories.  She is dual certified through the CCMG in Molecular Genetics (2006) and Cytogenetics (2008) and has been active with the CCMG through involvement in several standing and ad hoc committees.  She is currently the Program Director for the CCMG Genetics Fellowship Training Program through the Postgraduate Pathology and Molecular Medicine Program at McMaster University. 


Treasurer: Elizabeth (Beth) Spriggs, PhD, FCCMG

Beth Spriggs 200Beth Spriggs is the Medical Director, Genomics, Diagnostic Services, Shared Health Manitoba and is also cross-appointed to the Rady Faculty of Health Sciences, University of Manitoba as an Assistant Professor.  She has been involved with the CCMG since 1998 and has served as a member of the Molecular Genetics, Education, Accreditation of Centres, and Examinations Committees. She is also actively involved in the education of graduate students including those in Manitoba’s new Masters of Genetic Counselling program, RCPSC residents, and CCMG post-graduate trainees.


Member at LargeGraham Sinclair, PhD, FCCMG

Graham Sinclair 200Graham Sinclair is the laboratory head for the British Columbia Newborn Screening Program, a Biochemical Geneticist and clinical research division head at BC Children’s Hospital, and a Clinical Professor in the Department of Pathology and Laboratory Medicine at UBC. He is a past member of the CCMG Ethics and Public Policy Committee, and current member of the C&W UBC Research Ethics Board. His research activities focus on clinical applications of mass spectrometry and the use of metabolomics for the diagnosis and investigation of inborn errors of metabolism. 


Secretary: Lindsay Brown, PhD, FCCMG

Brown Lindsay 200Lindsay Brown is a Molecular Geneticist and Cytogeneticist in the Division of Genome Diagnostics at BC Children’s and Woman’s Hospital and a Clinical Associate Professor in the Department of Pathology and Laboratory Medicine at UBC. She is a past member of the CCMG Accreditation of Centres Committee. She is also actively involved in the direct training and overseeing of both molecular and cytogenetic CCMG fellows, as well as being involved in the education of Genetic Counselling students and RCPSC residents. 


Member at Large: Oana Caluseriu, MD, FRCPC, FCCMG

Caluseriu Oana 200Dr. Caluseriu practices primarily in the areas of pediatric genetics and prenatal diagnosis at the Stollery Children’s and Royal Alexandra Hospitals in Edmonton. Her research interest is focused around understanding the molecular basis of rare genetic disorders. A native of Romania, Dr. Caluseriu speaks four languages. She studied Medical Genetics at the Catholic University in Rome, and then, in 2001, followed that with a research Fellowship at the University of Toronto, completed a RCPSC residency in Medical Genetics at the University of Calgary and a CIHR Fellowship in Maternal and Child Health at the same center before joining the University of Alberta in 2012. Through her diverse background and expertise, she would like to represent the membership in the Board of Directors to help advance the impact of genetics in contemporary medicine and medical education, promote innovative delivery of services in the genomic era, and potentially enhance Canada’s presence as a global partner in the field. 

Member at Large: Sarah Dyack, MD, FRCPC, FCCMG

Sarah Dyack 150Sarah Dyack is a Clinical Geneticist and Associate Professor of Pediatrics and Medicine at Dalhousie University in Halifax, Nova Scotia. She completed her Royal College Residency training in Paediatrics at the University of Alberta and a CCMG fellowship in Clinical Genetics at the University of Toronto. She is Head of the Division of Medical Genetics and co-chair of the Maritime Newborn Screening Advisory Committee. She sees metabolic, pediatric, and cardiac genetics patients. Research interests include new gene discovery and Fabry disease. She has been a member of several CCMG committees including Awards and Nominations, Scientific Program, and Accreditation, and is currently serving on the neurodevelopmental disorders working group.

Member at Large: Mary Ann Thomas, MD CM, FRCPC, FCCMG

Mary Ann Thomas 200Mary Ann Thomas is an Associate Professor in Medical Genetics at the University of Calgary. She completed her Royal College Residency training in Medical Genetics and her CCMG fellowship in Cytogenetics at McGill University. She is a clinical geneticist and cytogeneticist at the Alberta Children’s Hospital and her clinical areas of interest include chromosome conditions/syndromes, prenatal genetics, and dysmorphology and is a medical consultant for the Alberta congenital anomalies surveillance system (ACASS).

She has been passionate about medical education and involved with teaching and formally supervising a broad range of learners throughout her career, including medical students, residents and CCMG fellows. She was the Calgary Program Director for the RCPSC residency program for 8 years, is the Western Canada representative on the RCPSC Medical Genetics and Genomics Specialties committee, and is the Calgary Genetics CBD (Competency by Design) Lead during its development and implementation. She has been on several CCMG committees and working groups since 2006.

Save the Dates!

Leading Strand  - Friday, May 27 at 12:00 PM ET - REGISTER

46th Annual Scientific Meeting - June 6-10, 2022 - Presented Virtually

CCMG Annual General Meeting - June 15, 2022 - Virtual Meeting

TeleGraf - Friday, June 17 at 11:00 AM ET - REGISTER